ChargePoint Technology and Famat Sampling’s combination technology is designed to allow for product sampling during the course of production.
ChargePoint Technology, a company specializing in powder transfer, and Famat Sampling, a company specializing in sampling devices, announced a collaboration technology on May 16, 2023. According to a company press release, the companies’ new integrated valve solution allows operators to take a product sample for quality analysis during the course of production while maintaining optimal containment and sterile integrity.
The new product, a combination of ChargePoint’s split butterfly valve and Famat’s 125-Threaded Cap/Occupational Exposure Limit valve, is designed to create a secure and sterile environment for high-potency and sterile powder samples to be taken. According to the release, the interconnected system forms an airtight seal that prevents a dead zone and allows for sampling of highly potent, toxic, or sterile powders to be transferred while maintaining Occupational Exposure Band 4 (OEB4) and OEB5 level compliance.
“During processing, manufacturers must prioritize sampling so that the quality of drug products can be assessed at various stages of the production process,” said Christian Dunne, head of Sterile Solutions, ChargePoint Technology, in the release. “Famat Sampling shares our high standards for quality. Joining forces as two recognized industry leaders in our respective fields was a no-brainer for our team.”
Source: ChargePoint Technology
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.